Insider: Birznieks Gunther SVP, Business Development - Vanda Pharmaceuticals Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 313,569 | 0 | 313,569 |
| Value | $1,599,201.90 | $0.00 | $1,599,201.90 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/05/2024 | DDS | 8,684 | Direct | COM | $4.13 | $35,884.02 | 313,569 |
| 03/04/2024 | DDS | 8,727 | Direct | COM | $4.30 | $37,494.68 | 322,253 |
| 03/03/2023 | DDS | 8,268 | Direct | COM | $6.26 | $51,790.75 | 205,980 |
| 03/02/2023 | DDS | 8,509 | Direct | COM | $6.20 | $52,793.24 | 214,248 |
| 03/02/2022 | DDS | 11,517 | Direct | COM | $11.27 | $129,791.98 | 188,807 |
| 03/01/2022 | DDS | 4,084 | Direct | COM | $11.19 | $45,699.96 | 200,324 |
| 03/02/2021 | DDS | 16,620 | Direct | COM | $18.19 | $302,272.93 | 171,708 |
| 03/01/2021 | DDS | 3,845 | Direct | COM | $18.66 | $71,743.86 | 188,328 |
| 03/03/2020 | DDS | 5,535 | Direct | COM | $10.66 | $58,984.28 | 159,473 |
| 03/02/2020 | DDS | 12,223 | Direct | COM | $10.04 | $122,685.92 | 165,008 |
| 01/02/2020 | DDS | 4,020 | Direct | COM | $15.93 | $64,021.31 | 147,231 |
| 03/04/2019 | DDS | 8,788 | Direct | COM | $19.89 | $174,766.96 | 151,251 |
| 03/01/2019 | DDS | 3,741 | Direct | COM | $20.14 | $75,325.04 | 160,039 |
| 01/03/2019 | DDS | 1,619 | Direct | COM | $26.09 | $42,231.62 | 133,780 |
| 01/02/2019 | DDS | 1,170 | Direct | COM | $26.95 | $31,527.99 | 135,399 |
| 01/02/2019 | DDS | 3,272 | Direct | COM | $26.30 | $86,050.33 | 136,569 |
| 03/01/2018 | DDS | 8,525 | Direct | COM | $18.72 | $159,605.05 | 139,841 |
| 01/02/2018 | DDS | 8,568 | Direct | COM | $15.26 | $130,776.81 | 118,366 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research